| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 电解质类药物(元) | 90,719,891.70 | 124,180,591.85 | 68,000,015.11 |
| 骨科药物(元) | 117,878,205.79 | 271,532,475.64 | 137,876,458.63 |
| 抗感染药物(元) | 17,361,370.74 | 51,035,223.15 | 21,318,781.27 |
| 抗肿瘤药物(元) | 41,640,390.27 | 128,810,627.71 | 73,213,260.12 |
| 肾病用药(元) | - | 15,948,437.56 | 7,761,491.02 |
| 维生素类药物(元) | 482,478,629.29 | 1,125,237,416.07 | 531,923,340.41 |
| 消化系统药物(元) | - | 9,924,575.00 | 6,727,325.93 |
| 心脑血管药物(元) | 307,805,064.71 | 669,503,324.71 | 356,430,709.20 |
| 其他用药领域(元) | 39,157,308.68 | 39,535,509.88 | 15,555,053.51 |
| 营业成本(元) | |||
| 电解质类药物(元) | 48,890,685.45 | 52,513,270.50 | - |
| 骨科药物(元) | 20,611,642.00 | 47,151,712.62 | 25,275,158.35 |
| 抗感染药物(元) | 9,730,798.40 | 38,870,015.73 | - |
| 抗肿瘤药物(元) | 8,231,471.31 | 25,824,659.60 | - |
| 肾病用药(元) | - | 12,452,447.72 | - |
| 维生素类药物(元) | 302,525,345.72 | 601,897,821.95 | 273,909,007.81 |
| 消化系统药物(元) | - | 5,503,482.27 | - |
| 心脑血管药物(元) | 165,798,793.37 | 329,974,903.07 | 179,190,383.53 |
| 其他用药领域(元) | 22,894,708.78 | 19,989,003.72 | - |
| 毛利(元) | |||
| 电解质类药物(元) | 41,829,206.25 | 71,667,321.35 | - |
| 骨科药物(元) | 97,266,563.79 | 224,380,763.02 | 112,601,300.28 |
| 抗感染药物(元) | 7,630,572.34 | 12,165,207.42 | - |
| 抗肿瘤药物(元) | 33,408,918.96 | 102,985,968.11 | - |
| 肾病用药(元) | - | 3,495,989.84 | - |
| 维生素类药物(元) | 179,953,283.57 | 523,339,594.12 | 258,014,332.60 |
| 消化系统药物(元) | - | 4,421,092.73 | - |
| 心脑血管药物(元) | 142,006,271.34 | 339,528,421.64 | 177,240,325.67 |
| 其他用药领域(元) | 16,262,599.90 | 19,546,506.16 | - |
| 毛利率(%) | |||
| 电解质类药物(%) | 46.11 | 57.71 | - |
| 骨科药物(%) | 82.51 | 82.63 | 81.67 |
| 抗感染药物(%) | 43.95 | 23.84 | - |
| 抗肿瘤药物(%) | 80.23 | 79.95 | - |
| 肾病用药(%) | - | 21.92 | - |
| 维生素类药物(%) | 37.30 | 46.51 | 48.51 |
| 消化系统药物(%) | - | 44.55 | - |
| 心脑血管药物(%) | 46.14 | 50.71 | 49.73 |
| 其他用药领域(%) | 41.53 | 49.44 | - |
| 收入构成(%) | |||
| 电解质类药物(%) | 8.27 | 5.10 | 5.58 |
| 骨科药物(%) | 10.75 | 11.15 | 11.31 |
| 抗感染药物(%) | 1.58 | 2.10 | 1.75 |
| 抗肿瘤药物(%) | 3.80 | 5.29 | 6.01 |
| 肾病用药(%) | - | 0.65 | 0.64 |
| 维生素类药物(%) | 43.98 | 46.20 | 43.64 |
| 消化系统药物(%) | - | 0.41 | 0.55 |
| 心脑血管药物(%) | 28.06 | 27.49 | 29.24 |
| 其他用药领域(%) | 3.57 | 1.62 | 1.28 |
| 毛利构成(%) | |||
| 电解质类药物(%) | 8.07 | 5.51 | 0.00 |
| 骨科药物(%) | 18.76 | 17.24 | 20.55 |
| 抗感染药物(%) | 1.47 | 0.93 | 0.00 |
| 抗肿瘤药物(%) | 6.45 | 7.91 | 0.00 |
| 肾病用药(%) | - | 0.27 | 0.00 |
| 维生素类药物(%) | 34.72 | 40.21 | 47.10 |
| 消化系统药物(%) | - | 0.34 | 0.00 |
| 心脑血管药物(%) | 27.40 | 26.09 | 32.35 |
| 其他用药领域(%) | 3.14 | 1.50 | 0.00 |